Contact
searchSearch
HMP Global

July 2014 - FRMC

Department
Specialty Pharmacy Trends Report: Hepatitis C
07/23/2014
Hepatitis C is a contagious disease of the liver caused by the hepatitis C virus (HCV) that ranges in severity from acute to chronic.
Hepatitis C is a contagious disease of the liver caused by the hepatitis C virus (HCV) that ranges in severity from acute to chronic.
Hepatitis C is a contagious...
07/23/2014
First Report Managed Care
Trends Report
Specialty Pharmacy Trends Report: Crohn`s Disease and Ulcerative Colitis
07/23/2014
Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that lead to long-lasting inflammation in the digestive tract.
Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that lead to long-lasting inflammation in the digestive tract.
Crohn’s disease and ulcerative...
07/23/2014
First Report Managed Care
Department
Specialty Pharmacy Trends Report: Asthma
07/23/2014
Asthma is a chronic lung disease that inflames and narrows the airways, causing recurring periods of wheezing, chest tightening, shortness of breath, and coughing. According to the Centers for Disease Control and Prevention, approximately 25...
Asthma is a chronic lung disease that inflames and narrows the airways, causing recurring periods of wheezing, chest tightening, shortness of breath, and coughing. According to the Centers for Disease Control and Prevention, approximately 25...
Asthma is a chronic lung disease...
07/23/2014
First Report Managed Care
News Connection
Complications with Insurance Coverage in Rural America
07/22/2014
Jordyn Greenblatt
The ACA expansion is an attempt to expand healthcare coverage among the rural population.
The ACA expansion is an attempt to expand healthcare coverage among the rural population.
The ACA expansion is an attempt...
07/22/2014
First Report Managed Care
Faldaprevir to Treat Patients with Hepatitis C
07/22/2014
Tim Casey
Chicago—Patients with genotype 1 hepatitis C who received faldaprevir plus pegylated interferon and ribavirin had an increase in sustained virologic response (SVR) after 12 and 24 weeks of treatment compared with a group that took pegylated...
Chicago—Patients with genotype 1 hepatitis C who received faldaprevir plus pegylated interferon and ribavirin had an increase in sustained virologic response (SVR) after 12 and 24 weeks of treatment compared with a group that took pegylated...
Chicago—Patients with genotype 1...
07/22/2014
First Report Managed Care
Treating Patients with Chronic Constipation or IBS
07/22/2014
Tim Casey
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS),...
07/22/2014
First Report Managed Care
Very Low Calorie Diet before Laparoscopic Cholecystectomy
07/22/2014
Tim Casey
Obese patients on a low calorie diet prior to undergoing a laparoscopic cholecystectomy procedure had a decrease in body weight and operation time.
Obese patients on a low calorie diet prior to undergoing a laparoscopic cholecystectomy procedure had a decrease in body weight and operation time.
Obese patients on a low calorie...
07/22/2014
First Report Managed Care
Bevacizumab or Cetuximab in Combination with Chemotherapy for mCRC
07/22/2014
Tim Casey
Chicago—Patients with metastatic colorectal cancer (mCRC) had no difference in overall survival or progression-free survival if they received bevacizumab plus chemotherapy or cetuximab plus chemotherapy for first-line treatment, according to...
Chicago—Patients with metastatic colorectal cancer (mCRC) had no difference in overall survival or progression-free survival if they received bevacizumab plus chemotherapy or cetuximab plus chemotherapy for first-line treatment, according to...
Chicago—Patients with metastatic...
07/22/2014
First Report Managed Care
Docetaxel plus Androgen Deprivation Therapy for Metastatic Prostate Cancer
07/22/2014
Tim Casey
Chicago—Patients with hormone-sensitive newly metastatic prostate cancer who received docetaxel with androgen deprivation therapy (ADT) had a significant improvement in overall survival compared with a group that received ADT alone, according...
Chicago—Patients with hormone-sensitive newly metastatic prostate cancer who received docetaxel with androgen deprivation therapy (ADT) had a significant improvement in overall survival compared with a group that received ADT alone, according...
Chicago—Patients with...
07/22/2014
First Report Managed Care
Healthcare Costs for Metastatic Melanoma Treatment Options
07/22/2014
Tim Casey
Chicago—A retrospective, observational study of healthcare claims data found that patients with metastatic melanoma who received vemurafenib had significantly lower healthcare costs during treatment compared with patients who received...
Chicago—A retrospective, observational study of healthcare claims data found that patients with metastatic melanoma who received vemurafenib had significantly lower healthcare costs during treatment compared with patients who received...
Chicago—A retrospective,...
07/22/2014
First Report Managed Care
Ramucirumab Improves Overall Survival in Patients with NSCLC
07/22/2014
Tim Casey
Chicago—Patients with advanced, progressive non-small cell lung cancer (NSCLC) who received ramucirumab plus docetaxel had a significant improvement in overall survival and progression-free survival compared with a group taking docetaxel and...
Chicago—Patients with advanced, progressive non-small cell lung cancer (NSCLC) who received ramucirumab plus docetaxel had a significant improvement in overall survival and progression-free survival compared with a group taking docetaxel and...
Chicago—Patients with advanced,...
07/22/2014
First Report Managed Care
Anti-VEGF Agents Show Improvement in Treatment of Myopic Choroidal Neovascularization
07/22/2014
Mary Mihalovic
Among patients with myopic choroidal neovascularization (CNV), the use of either of the 2 antivascular endothelial growth factor (VEGF) agents, ranibizumab or bevacizumab, led to functional and anatomical visual improvement, according to...
Among patients with myopic choroidal neovascularization (CNV), the use of either of the 2 antivascular endothelial growth factor (VEGF) agents, ranibizumab or bevacizumab, led to functional and anatomical visual improvement, according to...
Among patients with myopic...
07/22/2014
First Report Managed Care
Antivascular Endothelial Growth Factor Therapy Improves Visual Acuity, Reduces Clinical Burden
07/22/2014
Mary Mihalovic
Patients with neovascular age-related macular degeneration (nAMD) experienced improvement in visual acuity on an observe-and-plan regimen with the antivascular endothelial growth factor agent, ranibizumab, which also reduced clinical burden...
Patients with neovascular age-related macular degeneration (nAMD) experienced improvement in visual acuity on an observe-and-plan regimen with the antivascular endothelial growth factor agent, ranibizumab, which also reduced clinical burden...
Patients with neovascular...
07/22/2014
First Report Managed Care
Screening for HBV Infections in Adolescents and Adults
07/22/2014
Sarah O'Brien
In 2004, the United States Preventive Services Task Force (USPSTF) recommended against screening asymptomatic people for hepatitis B virus (HBV) infection on the basis of lack of evidence that screening would improve clinical outcomes,...
In 2004, the United States Preventive Services Task Force (USPSTF) recommended against screening asymptomatic people for hepatitis B virus (HBV) infection on the basis of lack of evidence that screening would improve clinical outcomes,...
In 2004, the United States...
07/22/2014
First Report Managed Care
Study Shows Bendamustine is Cost-Effective for Patients with CLL
07/22/2014
Mary Beth Nierengarten
Results of a pharmacoeconomic analysis showed that single-agent bendamustine is a cost-effective treatment option as first-line treatment for patients with Binet stage B or C chronic lymphocytic leukemia (CLL) compared to alemtuzumab and...
Results of a pharmacoeconomic analysis showed that single-agent bendamustine is a cost-effective treatment option as first-line treatment for patients with Binet stage B or C chronic lymphocytic leukemia (CLL) compared to alemtuzumab and...
Results of a pharmacoeconomic...
07/22/2014
First Report Managed Care
Rosuvastatin Has No Benefit, May Be Detrimental for Sepsis-Associated ARDS
07/22/2014
Mary Beth Nierengarten
Results of a large, multicenter, double-blind, randomized, placebo-controlled trial found that patients with sepsis-associated acute respiratory distress syndrome (ARDS) treated with rosuvastatin had no reduction in in-hospital mortality or...
Results of a large, multicenter, double-blind, randomized, placebo-controlled trial found that patients with sepsis-associated acute respiratory distress syndrome (ARDS) treated with rosuvastatin had no reduction in in-hospital mortality or...
Results of a large, multicenter,...
07/22/2014
First Report Managed Care
Determining the Necessary Care to Prevent Readmission for Heart Failure
07/22/2014
Sarah O'Brien
In the United States, heart failure is a leading cause of hospitalization, as 25% of patients hospitalized for heart failure are readmitted within 30 days. A recent systematic review was conducted for the Effective Health Care Program of the...
In the United States, heart failure is a leading cause of hospitalization, as 25% of patients hospitalized for heart failure are readmitted within 30 days. A recent systematic review was conducted for the Effective Health Care Program of the...
In the United States, heart...
07/22/2014
First Report Managed Care
Medicare and the Aging Population - Q&A with Barney S. Spivack, MD, FACP
07/22/2014
First Report Managed Care conducted an interview with Barney S. Spivack, MD, FACP, one of our Editorial Advisory Board members, to discuss how the aging population will affect Medicare coverage and spending now and in the future. Here you...
First Report Managed Care conducted an interview with Barney S. Spivack, MD, FACP, one of our Editorial Advisory Board members, to discuss how the aging population will affect Medicare coverage and spending now and in the future. Here you...
First Report Managed Care...
07/22/2014
First Report Managed Care
Many US Citizens Do Not Feel Impacted by ACA Heading into Midterm Elections
07/22/2014
Kerri Fitzgerald
Four years after the Patient Protection and Affordable Care Act (ACA) was passed and just months into the first year of healthcare exchanges, 6 in 10 Americans (60%) said they feel no direct personal impact of the law, according to a survey...
Four years after the Patient Protection and Affordable Care Act (ACA) was passed and just months into the first year of healthcare exchanges, 6 in 10 Americans (60%) said they feel no direct personal impact of the law, according to a survey...
Four years after the Patient...
07/22/2014
First Report Managed Care
Surgical Procedures for Obese Patients with Type 2 Diabetes
07/21/2014
Tim Casey
Obese patients with type 2 diabetes are commonly prescribed medications and are further encouraged to exercise and improve their diets. In recent years, however, Roux-en-Y gastric bypass surgery, laparoscopic adjustable gastric banding...
Obese patients with type 2 diabetes are commonly prescribed medications and are further encouraged to exercise and improve their diets. In recent years, however, Roux-en-Y gastric bypass surgery, laparoscopic adjustable gastric banding...
Obese patients with type 2...
07/21/2014
First Report Managed Care
Inspector General Finds Problems at US Department of Veterans Affairs’ Medical Facilities
07/21/2014
Tim Casey
Since 2005, the Office of the Inspector General (OIG) has issued 18 reports indicating scheduling issues, long wait times, and subpar patient care at US Department of Veterans Affairs (VA) facilities throughout the United States. None...
Since 2005, the Office of the Inspector General (OIG) has issued 18 reports indicating scheduling issues, long wait times, and subpar patient care at US Department of Veterans Affairs (VA) facilities throughout the United States. None...
Since 2005, the Office of the...
07/21/2014
Veterans Health Today

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Subscribe to receive the latest updates in managed care!

First Report Managed Care Newsletter

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

July 2014 Volume 11 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use